INTERNATIONAL PATENT: ALIGOS THERAPEUTICS, INC. FILES APPLICATION FOR "PD-L1 COMPOUNDS WITH A BICYCLIC GROUP"

GENEVA, Aug. 19 -- ALIGOS THERAPEUTICS, INC. (1 Corporate Drive, 2nd FloorSouth San Francisco, California 94080) filed a patent application (PCT/US2025/014617) for "PD-L1 COMPOUNDS WITH A BICYCLIC GROUP" on Feb 05, 2025. With publication no. WO/2025/171025, the details related to the patent application was published on Aug 14, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): WU, Tongfei (c/o Aligos Therapeutics, Inc.1 Corporate Drive, 2nd FloorSouth San Francisco, California 94080)

Abstract: The present disclosure relates to compounds that can be useful as inhibitors of PD-1, PD-Ll or the ...